Type-I interferons promote innate immune tolerance in macrophages exposed to Mycobacterium ulcerans vesicles
PLOS Pathogens · 2023
DOI: 10.1371/journal.ppat.1011479 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2023. Verfasst von Quentin Bernard und 9 weiteren Autor:innen. Beteiligte Einrichtung: Univ Angers, Nantes Université, INSERM, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302, Angers, France. Hauptthemen laut MEDLINE: Mycobacterium ulcerans, Interferon Type I, Buruli Ulcer. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondation pour la Recherche Médicale, Labex IGO, ANR, Agence National de la Recherche ANR.
Abstract (Originalsprache)
Buruli ulcer is a chronic infectious disease caused by Mycobacterium ulcerans . The pathogen persistence in host skin is associated with the development of ulcerative and necrotic lesions leading to permanent disabilities in most patients. However, few of diagnosed cases are thought to resolve through an unknown self-healing process. Using in vitro and in vivo mouse models and M . ulcerans purified vesicles and mycolactone, we showed that the development of an innate immune tolerance was only specific to macrophages from mice able to heal spontaneously. This tolerance mechanism depends on a type I interferon response and can be induced by interferon beta. A type I interferon signature was further detected during in vivo infection in mice as well as in skin samples from patients under antibiotics regiment. Our results indicate that type I interferon-related genes expressed in macrophages may promote tolerance and healing during infection with skin damaging pathogen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Univ Angers, Nantes Université, INSERM, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302, Angers, France.
- Nantes Université, INSERM, CRTI, Nantes, France.
- Laboratoire d'anatomo-pathologie, CHU Angers, Angers, France.
ORCID-Profile: Estelle Marion
Förderung
- Fondation pour la Recherche Médicale
- Labex IGO, ANR
- Agence National de la Recherche ANR
Zitieren
APA
Bernard, Q., Goumeidane, M., Chaumond, E., Robbe-Saule, M., Boucaud, Y., Esnault, L., Croué, A., Jullien, J., Marsollier, L., & Marion, E. (2023). Type-I interferons promote innate immune tolerance in macrophages exposed to Mycobacterium ulcerans vesicles. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011479
Vancouver
Bernard Q, Goumeidane M, Chaumond E, Robbe-Saule M, Boucaud Y, Esnault L, et al. Type-I interferons promote innate immune tolerance in macrophages exposed to Mycobacterium ulcerans vesicles. PLOS Pathogens. 2023. doi:10.1371/journal.ppat.1011479
BibTeX
@article{Bernard2023,
author = {Bernard, Quentin and Goumeidane, Maïssa and Chaumond, Emmanuel and Robbe-Saule, Marie and Boucaud, Yan and Esnault, Lucille and Croué, Anne and Jullien, Jerome and Marsollier, Laurent and Marion, Estelle},
title = {Type-I interferons promote innate immune tolerance in macrophages exposed to Mycobacterium ulcerans vesicles},
journal = {PLOS Pathogens},
year = {2023},
doi = {10.1371/journal.ppat.1011479}
}
EUVIMED